{"gene":"GLE1","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":2006,"finding":"Gle1 and inositol hexakisphosphate (InsP6) together stimulate the RNA-dependent ATPase activity of the DEAD-box protein Dbp5 at the nuclear pore complex. In vitro kinetic analysis showed InsP6 significantly increased Dbp5 ATPase activity in a Gle1-dependent manner and lowered the effective RNA concentration for half-maximal ATPase activity. Gle1 alone had minimal stimulatory effect. Maximal InsP6 binding required both Dbp5 and Gle1.","method":"In vitro ATPase kinetic assays, genetic suppression (overexpression of DBP5 suppressed mRNA export defects of ipk1 nup42 mutant)","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with kinetic analysis, replicated simultaneously by two independent labs (PMIDs 16783363 and 16783364)","pmids":["16783363"],"is_preprint":false},{"year":2006,"finding":"Gle1 directly binds InsP6 and this binding potentiates Gle1-mediated stimulation of Dbp5 ATPase and RNA-binding activities. A gle1 point mutant deficient for Dbp5 stimulation in vitro displays an mRNA export defect in vivo, establishing that Dbp5 activation is an essential function of Gle1.","method":"In vitro ATPase and RNA-binding assays, in vitro binding, dominant mutations in DBP5 and GLE1 that rescue InsP6-deficient mRNA export phenotypes, in vivo mRNA export assays","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution plus mutagenesis plus in vivo rescue, replicated simultaneously by independent lab (PMID 16783363)","pmids":["16783364"],"is_preprint":false},{"year":2008,"finding":"Gle1 and IP6 are required for efficient translation termination in S. cerevisiae; Gle1 physically interacts with translation termination factors. Additionally, Gle1 has a conserved physical association with the initiation factor eIF3, and gle1 mutants display genetic interactions with the eIF3 mutant nip1-1. gle1 mutants have defects in translation initiation independently of IP6.","method":"Genetic interaction analysis, co-immunoprecipitation (Gle1-eIF3 interaction), in vivo translation termination and initiation assays in yeast mutants","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, genetic epistasis, multiple orthogonal functional assays in single study","pmids":["18724935"],"is_preprint":false},{"year":2010,"finding":"Specific Gle1 residues are required for IP6 binding, and these same residues are needed for IP6-dependent Dbp5 stimulation in vitro. In vivo, IP6-binding mutants of Gle1 recapitulate all mRNA export and translation termination defects seen in IP6-depleted cells, establishing Gle1 as the primary target of IP6 for both processes.","method":"In vitro ATPase stimulation assays with Gle1 point mutants, in vivo mRNA export and translation termination assays in S. cerevisiae","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — structure-guided mutagenesis combined with in vitro biochemistry and in vivo phenotypic analysis, multiple orthogonal methods","pmids":["20371601"],"is_preprint":false},{"year":2011,"finding":"Nup159 is specifically required for ADP release from Dbp5, whereas Gle1-IP6 stimulates ATP binding to Dbp5, priming it for RNA loading. A Dbp5 mutant with reduced ADP binding bypasses the need for Nup159 interaction in vivo. Together, Nup159 and Gle1-IP6 regulate Dbp5 cycles by controlling its nucleotide-bound state, allowing multiple cycles of mRNP remodeling at the NPC.","method":"In vitro reconstitution ATPase assays, genetic suppressor analysis (dbp5-R256D/R259D bypass of Nup159), in vivo mRNA export assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution plus genetic epistasis plus in vivo phenotypic rescue, multiple orthogonal methods in one study","pmids":["21576266"],"is_preprint":false},{"year":2011,"finding":"ATP binding and hydrolysis are required for efficient Dbp5 association with NPCs. RNA-binding-deficient Dbp5 mutants are dominant-negative for mRNA export by competing with wild-type Dbp5 for Gle1 at NPCs. The Dbp5-Gle1 interaction is limiting for export and can be independent of Nup159. FRAP shows Dbp5 associates with NPCs for less than 1 second on average.","method":"Dominant-negative mutant analysis in yeast and human cells, FRAP (fluorescence recovery after photobleaching), in vivo mRNA export assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — dominant-negative competition assays, live-cell FRAP, multiple orthogonal methods, replicated in both yeast and human cells","pmids":["21576265"],"is_preprint":false},{"year":2011,"finding":"Gle1 physically and genetically interacts with the DEAD-box protein Ded1 (a translation initiation factor). Unlike its stimulation of Dbp5, Gle1 inhibits Ded1 ATPase activity in vitro, and this inhibition is independent of IP6. A gle1-4 mutant suppresses translation initiation defects in ded1-120 mutant. Gle1 inhibits translation in vitro in competent extracts.","method":"In vitro ATPase assay (Gle1 inhibition of Ded1), genetic suppressor analysis (gle1-4 suppresses ded1-120), in vitro translation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of inhibitory activity, genetic epistasis, in vitro translation assay, multiple orthogonal methods","pmids":["21949122"],"is_preprint":false},{"year":2003,"finding":"The N-terminal 29 residues of hGle1 constitute the hNup155-binding domain. The hGle1-hNup155 interaction is necessary for NPC localization of hGle1. hNup155 C-terminal 177 amino acids bind hGle1. Deletion of the N-terminal 29 residues of hGle1B abolished nuclear rim localization in HeLa cells.","method":"Yeast two-hybrid screen, in vitro binding assay, deletion analysis, fluorescence microscopy in HeLa cells","journal":"Molecular & cellular proteomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro binding plus deletion analysis plus cell localization, single lab","pmids":["14645504"],"is_preprint":false},{"year":2003,"finding":"hGle1 undergoes nucleocytoplasmic shuttling between the nucleus and cytoplasm. An internal 39-amino acid shuttling domain is necessary and sufficient for nucleocytoplasmic transport. Disruption of shuttling by a cell-permeable peptide impairs export of bulk poly(A)+ RNA and specific mRNA and reduces hGle1 localization at the nuclear envelope.","method":"Microinjection of recombinant hGle1, FRAP in live HeLa cells expressing EGFP-hGle1, cell-permeable peptide inhibition, mRNA export assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — live-cell FRAP, microinjection, peptide inhibition with functional mRNA export readout, multiple orthogonal methods","pmids":["12668658"],"is_preprint":false},{"year":2005,"finding":"The unique C-terminal 43 amino acid region of hGle1B mediates binding to the C-terminal non-FG region of nucleoporin hCG1/NPL1. hNup155, hGle1B, and hCG1 form a heterotrimeric complex in vitro. siRNA-mediated depletion of hCG1 causes hGle1 accumulation in cytoplasmic foci and inhibits Hsp70 mRNA export and Hsp70 protein production.","method":"In vitro binding assay (heterotrimeric complex reconstitution), siRNA knockdown, mRNA export assay, fluorescence microscopy","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vitro complex reconstitution, siRNA functional knockdown with mRNA export readout, multiple orthogonal methods","pmids":["16000379"],"is_preprint":false},{"year":2004,"finding":"Nab2, Gfd1, and Gle1 associate in a complex. Direct in vitro binding assay revealed a direct association between Nab2 and Gfd1. Nuclear export of Nab2 was blocked in a gle1 mutant at the restrictive temperature, placing Gle1 in the pathway for Nab2-bound mRNA export.","method":"Affinity isolation with recombinant proteins from yeast lysates, co-immunoprecipitation, in vitro binding assay, in vivo export assay in gle1 temperature-sensitive mutant","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal pulldowns plus in vivo epistasis, single lab","pmids":["15208322"],"is_preprint":false},{"year":2004,"finding":"Cytoplasmic production of IP6 by plasma membrane-anchored Ipk1 is sufficient to rescue mRNA export defects of a gle1-2 ipk1-4 synthetic lethal mutant, establishing that the IP6 requirement for Gle1-mediated mRNA export operates at the cytoplasmic face of the NPC.","method":"Genetic rescue (cytoplasm-restricted Ipk1 complementation of gle1-2 ipk1-4 synthetic lethal), spatial restriction of IP6-producing enzymes","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with spatial-restriction complementation, single lab","pmids":["15459192"],"is_preprint":false},{"year":2009,"finding":"Crystal structure of the C-terminal domain of Dbp5 (1.8 Å) revealed a RecA-like fold with a unique C-terminal alpha-helix and a loop connecting beta5 and alpha4 not present in other DExD/H-box proteins. Structure-guided mutagenesis identified charged surface residues whose mutation weakens Gle1 binding and inhibits Gle1-stimulated Dbp5 ATPase activity in vitro; the same mutations were unable to support yeast growth, demonstrating that Gle1-Dbp5 interaction is required for cellular mRNA export.","method":"X-ray crystallography (1.8 Å), structure-guided mutagenesis, in vitro ATPase stimulation assay, in vivo growth complementation assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus structure-guided mutagenesis validated by in vitro and in vivo assays, multiple orthogonal methods in one study","pmids":["19805289"],"is_preprint":false},{"year":2013,"finding":"Gle1 self-associates via its coiled-coil domain both in vitro and in living cells, forming ~26 nm diameter disk-shaped oligomeric particles visible by electron microscopy. The disease-causing FinMajor mutation (proline-phenylalanine-glutamine insertion) disrupts proper Gle1 oligomer formation. Correct Gle1 oligomerization is specifically required for mRNA export function but not for Gle1's roles in translation.","method":"In vitro self-association assay, live-cell imaging (fluorescence), electron microscopy, functional mRNA export and translation assays with oligomerization-deficient mutants","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — EM structural characterization, in vitro biochemistry, live-cell imaging, and functional separation-of-function mutants, multiple orthogonal methods","pmids":["24243016"],"is_preprint":false},{"year":2017,"finding":"The Nup42 C-terminal domain (CTD) binds Gle1/hGle1B at an interface distinct from the Gle1-Dbp5 interaction site. A trimeric Nup42-CTD/Gle1-CTD/Dbp5 complex forms in the presence of IP6. Deletion of NUP42 abrogates the Gle1-Dbp5 interaction. In vitro, Nup42-CTD and IP6 stimulate Gle1/hGle1B activation of Dbp5 and hDDX19B in similar, non-additive manners. Disruption of the Nup42 or IP6 binding interfaces on Gle1/hGle1B causes defective mRNA export in yeast and human cells.","method":"In vitro ATPase stimulation assay, trimeric complex reconstitution, genetic deletion analysis, mRNA export assay in yeast and human cells, structure-function mutagenesis","journal":"Traffic (Copenhagen, Denmark)","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of trimeric complex, ATPase assays, validated in both yeast and human cells with multiple mutants","pmids":["28869701"],"is_preprint":false},{"year":2017,"finding":"Gle1 inhibits Ded1 RNA binding to reduce Ded1 ATPase activity and repress translation, acting as a gatekeeper to optimize Ded1 activity. Mutation analysis and binding assays show Gle1 inhibits Ded1 by reducing its affinity for RNA. Both Ded1 and Gle1 affect assembly of preinitiation complexes.","method":"In vitro ATPase assay, RNA-binding assay, in vivo translation assays, genetic epistasis (GLE1 suppression of DED1 overexpression defects), preinitiation complex assembly assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of inhibitory mechanism (RNA binding), in vivo genetic validation, multiple orthogonal methods","pmids":["28784717"],"is_preprint":false},{"year":2018,"finding":"Human Gle1 is regulated by phosphorylation during heat shock stress. MS identified 14 phosphorylation sites in Gle1A, with six clustering in an N-terminal intrinsically disordered region. ERK and JNK phosphorylate the Gle1A N-terminal domain, priming it for glycogen synthase kinase 3 (GSK3) phosphorylation. A phosphomimetic gle1A6D variant perturbed self-association and inhibited DDX3 ATPase activity. Phosphodeficient GFP-gle1A6A promoted stress granule assembly, whereas GFP-gle1A6D enhanced stress granule disassembly.","method":"Mass spectrometry (phosphosite identification), in vitro kinase assay (ERK, JNK, GSK3), phosphomimetic and phosphodeficient mutant analysis, in vitro ATPase assay (DDX3 inhibition), stress granule imaging in HeLa cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — MS-identified sites validated by in vitro kinase assays, ATPase inhibition, and functional cell biology with phosphomimetic mutants, multiple orthogonal methods","pmids":["30429220"],"is_preprint":false},{"year":2018,"finding":"Gle1A isoform is required for proper stress granule formation and the sodium arsenite survival response in HeLa cells. Gle1B functions in mRNA export at the nuclear pore complex. The two isoforms have spatially distinct functions: Gle1A in cytoplasmic stress granules, Gle1B at the nuclear envelope.","method":"siRNA knockdown of hGle1, overexpression of Gle1A isoform, stress granule imaging, cell survival assay","journal":"Advances in biological regulation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific knockdown/overexpression with functional stress granule and survival readouts, single lab","pmids":["30262214"],"is_preprint":false},{"year":2016,"finding":"Gle1 localizes to centrosomes and basal bodies, assembling into the toroid-shaped pericentriolar material around the mother centriole. Reduced Gle1 levels correlate with decreased pericentrin localization and microtubule organization defects independently of mRNA export loss. In Gle1-depleted zebrafish, Kupffer's vesicle shows compromised ciliary beating and developmental defects.","method":"Fluorescence microscopy (localization), siRNA/morpholino knockdown, centrosome/microtubule phenotype analysis, zebrafish ciliary beating assay","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization by fluorescence microscopy with functional consequence (microtubule organization, ciliary beating), single lab","pmids":["28035044"],"is_preprint":false},{"year":2022,"finding":"Gle1 activates Dbp5 by two mechanisms: (1) Gle1 binding to Dbp5-ATP is thermodynamically coupled, with Gle1 binding Dbp5-ATP >100-fold more tightly than other nucleotide states, slowing ATP dissociation >150-fold; (2) Gle1 accelerates the rate-limiting phosphate (Pi) release step ~20-fold. These activities ensure a pool of ATP-bound Dbp5 at NPCs for RNA engagement during export.","method":"In vitro kinetic and equilibrium ATPase analysis (stopped-flow, fluorescence-based assays) with S. cerevisiae Gle1 and Dbp5","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — detailed kinetic reconstitution with multiple equilibrium and rate measurements, single lab but multiple orthogonal biochemical approaches","pmids":["35286399"],"is_preprint":false},{"year":2018,"finding":"Nup159 did not accelerate ADP release from Dbp5, contradicting the proposed nucleotide exchange factor model. Instead, Gle1 slowed ADP release from Dbp5 independent of Mg2+. In the presence of Nup159, the Gle1-ADP-Dbp5 interaction was reduced ~18-fold, suggesting Nup159 promotes Gle1 release from Dbp5 rather than ADP release.","method":"In vitro solution-based kinetic and thermodynamic assays (nucleotide binding/release measurements)","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — rigorous in vitro kinetics, but single lab; directly contradicts prior model (negative finding for Nup159 as ADP release factor)","pmids":["29782832"],"is_preprint":false},{"year":2020,"finding":"Gle1 self-association is driven by two distinct regions: a coiled-coil domain and a novel 10-amino acid aggregation-prone region. Gle1 oligomerization is necessary for mRNA export and stress granule formation (additively requiring both domains) and for translation regulation under stress (each domain independently required). Gle1 self-association is dispensable for phosphorylation and non-stressed translation initiation.","method":"Mutagenesis of oligomerization domains, exogenous expression in HeLa cells, mRNA export assay, stress granule imaging, translation assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic mutagenesis with multiple functional readouts, single lab","pmids":["32981894"],"is_preprint":false},{"year":2020,"finding":"Gle1 physically interacts with the RNA-binding E3 ubiquitin ligase MKRN2. In zebrafish, morpholino knockdown or CRISPR/Cas9 knockout of MKRN2 partially rescues retinal developmental defects caused by GLE1 depletion, establishing a functional epistatic relationship between GLE1 and MKRN2 in mRNA export and retinal development.","method":"Affinity-purification mass spectrometry (interaction identification), morpholino knockdown, CRISPR/Cas9 knockout, zebrafish genetic epistasis (rescue assay), ribonomic analysis","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — AP-MS interaction plus genetic epistasis in zebrafish, single lab","pmids":["32460013"],"is_preprint":false},{"year":2020,"finding":"Nuclear accumulation of Gle1 (via shuttling inhibition) results in accumulation of specific mRNAs with elongated 3'-UTRs due to altered transcription termination, not altered nuclear export. Gle1 shuttling inhibition increased DDX1 nucleoplasmic localization and decreased DDX1 interactions with Gle1 and with CstF-64 (pre-mRNA cleavage stimulation factor). Gle1 colocalized with nuclear R-loops, and shuttling inhibition increased nuclear R-loop signal intensity.","method":"Cell-permeable peptide to disrupt shuttling, RNA-seq/mRNA accumulation analysis, immunofluorescence (DDX1, R-loop localization), co-immunoprecipitation (Gle1-DDX1-CstF-64 interaction)","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional peptide inhibition combined with co-IP and localization, multiple orthogonal methods, single lab","pmids":["32755435"],"is_preprint":false},{"year":2023,"finding":"Phosphorylation of Gle1 at threonine 102 (T102) serves as a priming event for further N-terminal phosphorylation. Basally phosphorylated (T102) Gle1 is predominantly nuclear; under sodium arsenite stress, more cytoplasmic localization is detected. Gle1-pT102 co-immunoprecipitates with DDX1 in a phosphatase-sensitive manner. Disruption of Gle1 nucleocytoplasmic shuttling decreased total Gle1-DDX1 association but increased co-isolation of Gle1-pT102 with DDX1.","method":"Phospho-specific antibody generation, in vitro kinase assay, indirect immunofluorescence microscopy, co-immunoprecipitation","journal":"Advances in biological regulation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro kinase assay plus phospho-specific antibody with co-IP and localization readouts, single lab","pmids":["37801910"],"is_preprint":false},{"year":2024,"finding":"Gle1 binding to Dbp5 (via the Gle1-Dbp5 interaction interface) is required for Dbp5 to mediate tRNA export in vivo, as shown by dominant-negative Dbp5 mutants. tRNA acts synergistically with Gle1 to fully activate Dbp5 ATPase activity; direct Dbp5-tRNA interaction alone does not stimulate ATPase activity.","method":"In vitro ATPase assay (Dbp5 + tRNA ± Gle1), dominant-negative overexpression in vivo, co-immunoprecipitation (Dbp5-tRNA), genetic epistasis (dbp5 mutants parallel to los1)","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — in vitro biochemistry plus in vivo genetics, single lab","pmids":["38189406"],"is_preprint":false},{"year":2005,"finding":"hGle1 localization to nuclear pore complexes requires interaction with hCG1 (via the unique C-terminal 43 aa of hGle1B); siRNA-mediated depletion of hCG1 causes hGle1 accumulation in cytoplasmic foci, indicating hCG1 is required for NPC localization of hGle1. This parallels the yeast Gle1-Nup42/Rip1 interaction.","method":"siRNA knockdown, fluorescence microscopy, in vitro binding/complex assembly assay","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with fluorescence localization readout plus in vitro binding, single lab","pmids":["16000379"],"is_preprint":false},{"year":2015,"finding":"An ALS-linked hGLE1 splice site mutation (c.1965-2A>C) generates a novel protein isoform (hGle1-IVS14-2A>C) with an 88 amino acid C-terminal insertion. This isoform localizes to stress granules (like hGle1A), rescues stress granule defects upon hGle1 depletion, and can also rescue mRNA export defects — acting in a bi-functional manner combining hGle1A and hGle1B functions. Both hGle1A and hGle1-IVS14-2A>C overexpression induced cytoplasmic protein aggregates.","method":"Molecular cloning of mutant isoform, GFP-tagged localization by fluorescence microscopy, siRNA rescue assay (stress granule and mRNA export), overexpression aggregate formation","journal":"Advances in biological regulation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional isoform characterization with multiple cellular readouts, single lab","pmids":["26776475"],"is_preprint":false},{"year":2014,"finding":"Two deleterious ALS-linked hGLE1 mutations cause depletion of hGle1 from the nuclear pore in HeLa cells and fail to rescue motor neuron pathology in zebrafish morphants lacking Gle1, consistent with haploinsufficiency as the ALS mechanism.","method":"Fluorescence microscopy (hGle1 nuclear pore localization in HeLa), zebrafish morphant rescue assay","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell localization plus in vivo zebrafish rescue assay, single lab","pmids":["25343993"],"is_preprint":false},{"year":2025,"finding":"Crystal structure of N-terminally truncated Gle1 from Debaryomyces hansenii (DhGle1ΔN) was determined at 1.5 Å resolution, revealing 13 α-helices. Structural comparison with homologs showed no significant conformational changes upon complex formation, but identified distinct secondary structural elements in α1, α3, α4, and α8 that may be relevant to partner interactions.","method":"X-ray crystallography (1.5 Å), structural comparison with homologs","journal":"International journal of molecular sciences","confidence":"Low","confidence_rationale":"Tier 1 / Weak — crystal structure determined but no functional mutagenesis validation reported in abstract; single study, fungal ortholog","pmids":["40004126"],"is_preprint":false}],"current_model":"GLE1 is a conserved, multifunctional regulator of RNA-dependent DEAD-box ATPases that localizes to the cytoplasmic face of nuclear pore complexes (via interactions with Nup155 and hCG1/Nup42) through nucleocytoplasmic shuttling; at the NPC, GLE1 bound to inositol hexakisphosphate (IP6) activates the DEAD-box protein Dbp5 by promoting ATP binding and accelerating rate-limiting phosphate release, thereby driving mRNP remodeling for directional mRNA export, while Nup159 facilitates Gle1 release from Dbp5 after each cycle; beyond export, GLE1 independently regulates translation initiation by inhibiting Ded1 RNA-binding activity, coordinates translation termination together with IP6 and Dbp5, controls stress granule dynamics through isoform-specific (Gle1A) cytoplasmic functions regulated by MAPK/GSK3-mediated phosphorylation, participates in transcription termination via nuclear DDX1 interactions, and localizes to centrosomes/basal bodies where it supports microtubule organization; loss-of-function mutations in GLE1 cause lethal congenital contracture syndrome 1 (LCCS1) and related motor neuron diseases by disrupting oligomerization-dependent mRNA export and broader mRNA metabolism."},"narrative":{"mechanistic_narrative":"GLE1 is a conserved, multifunctional regulator of RNA-dependent DEAD-box ATPases that governs directional mRNA export at the nuclear pore complex (NPC) and additionally tunes translation [PMID:16783363, PMID:21949122]. At the cytoplasmic face of the NPC, GLE1 bound to inositol hexakisphosphate (IP6) activates the DEAD-box protein Dbp5: GLE1-IP6 promotes ATP binding to prime Dbp5 for RNA loading and accelerates the rate-limiting phosphate release step, thereby driving the mRNP-remodeling cycles required for export [PMID:16783363, PMID:16783364, PMID:21576266, PMID:35286399]. Specific GLE1 residues mediate IP6 binding, and the same residues are required for Dbp5 stimulation in vitro and for mRNA export and translation termination in vivo, establishing IP6-bound GLE1 as the operative activating species [PMID:20371601]. GLE1 is recruited to the NPC through its nucleoporin contacts—an N-terminal hNup155-binding domain and a C-terminal hCG1/Nup42-binding region that together with Dbp5 and IP6 assemble an activating complex—and through nucleocytoplasmic shuttling that is itself required for efficient poly(A)+ RNA export [PMID:14645504, PMID:16000379, PMID:28869701, PMID:12668658]. GLE1 self-associates through a coiled-coil and an aggregation-prone region into disk-shaped oligomers; this oligomerization is specifically required for mRNA export but separable from its translation roles, and the disease-causing FinMajor insertion disrupts it [PMID:24243016, PMID:32981894]. Beyond export, GLE1 acts as a translational gatekeeper by inhibiting the DEAD-box initiation factor Ded1 through reduction of its RNA-binding affinity, an IP6-independent activity, and cooperates with IP6 and Dbp5 in translation termination [PMID:21949122, PMID:28784717, PMID:18724935]. An isoform-specific cytoplasmic function (Gle1A), regulated by ERK/JNK-primed GSK3 phosphorylation, controls stress-granule assembly and disassembly and modulates DDX3 activity, while GLE1 also influences transcription termination via DDX1 interactions and localizes to centrosomes to support microtubule organization [PMID:30429220, PMID:30262214, PMID:28035044, PMID:32755435]. Loss-of-function GLE1 mutations cause lethal congenital contracture syndrome 1 and ALS-associated motor neuron pathology by depleting GLE1 from the NPC and disrupting oligomerization-dependent mRNA export [PMID:24243016, PMID:25343993].","teleology":[{"year":2006,"claim":"Established the core biochemical function of GLE1: how an inositol phosphate cofactor and GLE1 jointly switch on the export ATPase Dbp5, resolving how nucleotide-dependent mRNP remodeling is activated at the pore.","evidence":"In vitro ATPase kinetics and in vitro IP6/protein binding with genetic suppression in yeast, replicated by two independent labs","pmids":["16783363","16783364"],"confidence":"High","gaps":["Did not define the GLE1 residues mediating IP6 binding","Mechanism by which IP6 alters Dbp5 kinetics not yet resolved at the step level"]},{"year":2004,"claim":"Localized the IP6 requirement to the cytoplasmic face of the NPC, showing GLE1-dependent export operates spatially where mRNP is released.","evidence":"Genetic rescue with cytoplasm-restricted Ipk1 in gle1-2 ipk1-4 synthetic-lethal yeast","pmids":["15459192"],"confidence":"Medium","gaps":["Single lab","Did not directly visualize the activating complex at the pore"]},{"year":2003,"claim":"Defined how GLE1 reaches the NPC—identifying a discrete Nup155-binding domain and nucleocytoplasmic shuttling as prerequisites for nuclear-rim localization and bulk mRNA export.","evidence":"Yeast two-hybrid, in vitro binding, deletion analysis, microinjection and FRAP in HeLa cells with mRNA export readout","pmids":["14645504","12668658"],"confidence":"High","gaps":["Did not identify the shuttling receptor","Relationship between shuttling and Dbp5 activation not addressed"]},{"year":2005,"claim":"Identified the second nucleoporin anchor (hCG1/Nup42) and reconstituted a Nup155-Gle1B-hCG1 heterotrimer, showing both contacts are needed for NPC retention and efficient mRNA export.","evidence":"In vitro complex reconstitution, siRNA depletion of hCG1, mRNA export and protein production assays","pmids":["16000379"],"confidence":"High","gaps":["Did not place hCG1 mechanistically in the Dbp5 activation cycle (resolved later)","Single lab for human system"]},{"year":2008,"claim":"Extended GLE1 function beyond export to translation, demonstrating roles in termination (with IP6) and initiation (via eIF3) that are partly IP6-independent.","evidence":"Genetic interaction analysis, reciprocal co-IP, in vivo translation termination and initiation assays in yeast","pmids":["18724935"],"confidence":"High","gaps":["Molecular target of the initiation activity not identified here","Did not separate export from translation functions structurally"]},{"year":2009,"claim":"Provided the structural basis of the Gle1-Dbp5 interface, mapping surface residues whose mutation abolishes stimulation and cell viability.","evidence":"1.8 Å crystal structure of Dbp5 C-terminal domain with structure-guided mutagenesis and in vitro/in vivo assays","pmids":["19805289"],"confidence":"High","gaps":["No structure of the GLE1-IP6-Dbp5 complex","GLE1 conformation in the complex unresolved"]},{"year":2010,"claim":"Pinpointed GLE1 as the primary IP6 target, showing the IP6-binding residues are required for both export and translation termination in vivo.","evidence":"Structure-guided GLE1 point mutants in in vitro ATPase and in vivo export/termination assays in yeast","pmids":["20371601"],"confidence":"High","gaps":["Did not address how IP6 binding feeds into the kinetic steps of Dbp5 cycling"]},{"year":2011,"claim":"Resolved the directionality of the Dbp5 cycle, dividing labor between GLE1-IP6 (ATP binding/RNA loading) and Nup159 (downstream release), and showed the Gle1-Dbp5 interaction is the limiting export step with sub-second pore dwell time.","evidence":"In vitro reconstitution ATPase assays, genetic suppressor bypass, dominant-negative competition, and FRAP in yeast and human cells","pmids":["21576266","21576265"],"confidence":"High","gaps":["Mechanism of Nup159 action initially modeled as ADP release was later revised","Did not directly measure ATP-binding or Pi-release rate constants"]},{"year":2011,"claim":"Revealed that GLE1 acts oppositely on different DEAD-box proteins—inhibiting the initiation factor Ded1 in an IP6-independent manner—establishing GLE1 as a bidirectional ATPase regulator.","evidence":"In vitro ATPase and translation assays with genetic suppressor analysis (gle1-4 suppresses ded1-120)","pmids":["21949122"],"confidence":"High","gaps":["Mechanism of Ded1 inhibition not yet defined (later shown to be via RNA binding)"]},{"year":2013,"claim":"Showed GLE1 self-assembles into oligomeric particles and that this oligomerization is selectively required for export but not translation, linking it directly to disease via the FinMajor mutation.","evidence":"In vitro self-association, EM, live-cell imaging, and separation-of-function mutants in export/translation assays","pmids":["24243016"],"confidence":"High","gaps":["Atomic structure of the oligomer not determined","How oligomerization couples to Dbp5 activation unclear"]},{"year":2017,"claim":"Integrated the nucleoporin anchor into the activation mechanism, showing Nup42-CTD and IP6 non-additively stimulate GLE1 activation of Dbp5/DDX19B as part of a trimeric complex.","evidence":"In vitro trimeric complex reconstitution, ATPase assays, and export assays in yeast and human cells","pmids":["28869701"],"confidence":"High","gaps":["Did not resolve a structure of the full activating assembly"]},{"year":2017,"claim":"Defined the molecular mechanism of Ded1 repression—GLE1 reduces Ded1 RNA affinity to act as a translation-initiation gatekeeper affecting preinitiation complex assembly.","evidence":"In vitro ATPase and RNA-binding assays, in vivo translation assays, genetic epistasis, preinitiation complex assays","pmids":["28784717"],"confidence":"High","gaps":["Structural basis of the GLE1-Ded1 interaction unknown"]},{"year":2018,"claim":"Established phospho-regulation of cytoplasmic GLE1 (Gle1A), showing an ERK/JNK-primed, GSK3-driven phospho-code controls self-association, DDX3 activity, and stress-granule dynamics.","evidence":"Mass spectrometry, in vitro kinase assays, phosphomimetic/phosphodeficient mutants, ATPase assays, and stress-granule imaging in HeLa cells","pmids":["30429220"],"confidence":"High","gaps":["In vivo physiological triggers of each kinase event not mapped","Single lab for stress-granule phenotypes"]},{"year":2018,"claim":"Assigned spatially distinct roles to the GLE1 isoforms—Gle1A in cytoplasmic stress-granule formation and survival, Gle1B at the nuclear envelope for export.","evidence":"Isoform-specific siRNA/overexpression with stress-granule imaging and survival assays in HeLa cells","pmids":["30262214"],"confidence":"Medium","gaps":["Single lab","Endogenous isoform ratios and switching not quantified"]},{"year":2018,"claim":"Revised the Nup159 model, showing in solution kinetics that Nup159 does not accelerate ADP release but instead promotes GLE1 release from Dbp5.","evidence":"In vitro solution kinetic and thermodynamic nucleotide binding/release measurements","pmids":["29782832"],"confidence":"Medium","gaps":["Single lab; contradicts earlier model and awaits independent reconciliation","In vivo relevance of the revised mechanism not tested directly"]},{"year":2020,"claim":"Dissected the two self-association determinants of GLE1 and their differential requirements across export, stress-granule formation, and stress translation.","evidence":"Mutagenesis of oligomerization domains with export, stress-granule, and translation readouts in HeLa cells","pmids":["32981894"],"confidence":"Medium","gaps":["Single lab","Structural mechanism of the aggregation-prone region not resolved"]},{"year":2020,"claim":"Implicated GLE1 in transcription termination, showing shuttling inhibition causes 3'-UTR elongation, altered DDX1/CstF-64 interactions, and increased nuclear R-loops independent of export.","evidence":"Cell-permeable shuttling-disruption peptide, RNA-seq, immunofluorescence, and co-IP","pmids":["32755435"],"confidence":"Medium","gaps":["Single lab","Direct enzymatic role of GLE1 in termination not established"]},{"year":2020,"claim":"Identified a new physical and functional partner, the E3 ligase MKRN2, with genetic epistasis linking GLE1 and MKRN2 in mRNA export and retinal development.","evidence":"AP-MS, zebrafish morpholino/CRISPR knockout rescue, ribonomic analysis","pmids":["32460013"],"confidence":"Medium","gaps":["Single lab","Mechanistic basis of the GLE1-MKRN2 functional interaction unresolved"]},{"year":2022,"claim":"Provided the quantitative kinetic mechanism of Dbp5 activation, showing GLE1 thermodynamically traps the ATP-bound state and accelerates the rate-limiting Pi-release step.","evidence":"Stopped-flow and equilibrium ATPase kinetic analysis with yeast GLE1 and Dbp5","pmids":["35286399"],"confidence":"High","gaps":["Single lab","Structural snapshots of the kinetic intermediates not obtained"]},{"year":2023,"claim":"Identified GLE1 T102 as a priming phosphosite that biases nuclear localization and modulates phosphatase-sensitive DDX1 association.","evidence":"Phospho-specific antibody, in vitro kinase assay, immunofluorescence, and co-IP","pmids":["37801910"],"confidence":"Medium","gaps":["Single lab","Functional consequence of T102 phosphorylation for export/termination not directly tested"]},{"year":2024,"claim":"Extended GLE1-Dbp5 function to tRNA export, showing the Gle1-Dbp5 interface is required in vivo and that tRNA synergizes with GLE1 to fully activate Dbp5 ATPase activity.","evidence":"In vitro ATPase assays, dominant-negative overexpression, co-IP, and genetic epistasis in yeast","pmids":["38189406"],"confidence":"Medium","gaps":["Single lab","Whether human GLE1 supports tRNA export not addressed"]},{"year":2015,"claim":"Connected GLE1 to motor neuron disease at the molecular level, characterizing an ALS-linked splice isoform with combined export and stress-granule functions.","evidence":"Molecular cloning, GFP-localization, siRNA rescue assays, and aggregate-formation analysis","pmids":["26776475"],"confidence":"Medium","gaps":["Single lab","Pathogenic mechanism of the cytoplasmic aggregates not established"]},{"year":2014,"claim":"Demonstrated that ALS-linked GLE1 mutations deplete GLE1 from the NPC and fail to rescue motor neuron pathology, supporting haploinsufficiency as the disease mechanism.","evidence":"Fluorescence microscopy in HeLa and zebrafish morphant rescue assays","pmids":["25343993"],"confidence":"Medium","gaps":["Single lab","Did not establish a mammalian in vivo model of the disease"]},{"year":2025,"claim":"Provided a high-resolution structure of a fungal GLE1 ortholog, identifying secondary-structure elements potentially relevant to partner interactions.","evidence":"1.5 Å X-ray crystallography of DhGle1ΔN with structural comparison to homologs","pmids":["40004126"],"confidence":"Low","gaps":["No functional mutagenesis validation","Fungal ortholog; relevance to human GLE1 interfaces not tested"]},{"year":null,"claim":"How GLE1's distinct activities—export-coupled Dbp5 activation, Ded1/DDX3 inhibition, transcription termination, and centrosomal microtubule organization—are coordinated within a single cell, and the structure of the assembled GLE1-IP6-Dbp5-nucleoporin activating complex, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structure of the full activating complex","Mechanism integrating nuclear and cytoplasmic GLE1 functions unknown","Centrosomal role mechanistically uncharacterized at the molecular level"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,6,15,19]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[1]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[1,3]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[7,9,14]}],"localization":[{"term_id":"GO:0005635","term_label":"nuclear envelope","supporting_discovery_ids":[7,8,9,17]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[8,16,17]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[8,24]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[18]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[0,1,4,14]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[2,6,15]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[8,9]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[16,17]}],"complexes":["Nup155-Gle1B-hCG1/Nup42 NPC complex","Gle1-IP6-Dbp5 activating complex","Gle1 coiled-coil homo-oligomer"],"partners":["DBP5/DDX19B","NUP155","NUP42","DED1","DDX1","DDX3","MKRN2","NAB2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q53GS7","full_name":"mRNA export factor GLE1","aliases":["GLE1 RNA export mediator","GLE1-like protein","Nucleoporin GLE1"],"length_aa":698,"mass_kda":79.8,"function":"Required for the export of mRNAs containing poly(A) tails from the nucleus into the cytoplasm. May be involved in the terminal step of the mRNA transport through the nuclear pore complex (NPC)","subcellular_location":"Cytoplasm; Nucleus, nuclear pore complex","url":"https://www.uniprot.org/uniprotkb/Q53GS7/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/GLE1","classification":"Common Essential","n_dependent_lines":973,"n_total_lines":1208,"dependency_fraction":0.8054635761589404},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"RAN","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/GLE1","total_profiled":1310},"omim":[{"mim_id":"621395","title":"DEAD-BOX HELICASE 19A; DDX19A","url":"https://www.omim.org/entry/621395"},{"mim_id":"616886","title":"GSE1 COILED-COIL PROTEIN; GSE1","url":"https://www.omim.org/entry/616886"},{"mim_id":"611890","title":"CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD","url":"https://www.omim.org/entry/611890"},{"mim_id":"605812","title":"DEAD-BOX HELICASE 19B; DDX19B","url":"https://www.omim.org/entry/605812"},{"mim_id":"603371","title":"GLE1, RNA EXPORT MEDIATOR; GLE1","url":"https://www.omim.org/entry/603371"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nuclear membrane","reliability":"Supported"},{"location":"Nucleoli","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/GLE1"},"hgnc":{"alias_symbol":["hGLE1"],"prev_symbol":["GLE1L","LCCS1"]},"alphafold":{"accession":"Q53GS7","domains":[{"cath_id":"1.25.40.510","chopping":"411-698","consensus_level":"medium","plddt":92.1594,"start":411,"end":698},{"cath_id":"1.10.287","chopping":"257-347","consensus_level":"medium","plddt":80.5633,"start":257,"end":347}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q53GS7","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q53GS7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q53GS7-F1-predicted_aligned_error_v6.png","plddt_mean":78.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GLE1","jax_strain_url":"https://www.jax.org/strain/search?query=GLE1"},"sequence":{"accession":"Q53GS7","fasta_url":"https://rest.uniprot.org/uniprotkb/Q53GS7.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q53GS7/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q53GS7"}},"corpus_meta":[{"pmid":"16783363","id":"PMC_16783363","title":"Inositol hexakisphosphate and Gle1 activate the DEAD-box protein Dbp5 for nuclear mRNA export.","date":"2006","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16783363","citation_count":239,"is_preprint":false},{"pmid":"16783364","id":"PMC_16783364","title":"Activation of the DExD/H-box protein Dbp5 by the nuclear-pore protein Gle1 and its coactivator InsP6 is required for mRNA export.","date":"2006","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16783364","citation_count":226,"is_preprint":false},{"pmid":"18204449","id":"PMC_18204449","title":"Mutations in mRNA export mediator GLE1 result in a fetal motoneuron disease.","date":"2008","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18204449","citation_count":155,"is_preprint":false},{"pmid":"18724935","id":"PMC_18724935","title":"The mRNA export factor Gle1 and inositol hexakisphosphate regulate distinct stages of translation.","date":"2008","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/18724935","citation_count":127,"is_preprint":false},{"pmid":"25343993","id":"PMC_25343993","title":"Deleterious mutations in the essential mRNA metabolism factor, hGle1, in amyotrophic lateral sclerosis.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25343993","citation_count":116,"is_preprint":false},{"pmid":"21576266","id":"PMC_21576266","title":"The Dbp5 cycle at the nuclear pore complex during mRNA export II: nucleotide cycling and mRNP remodeling by Dbp5 are controlled by Nup159 and Gle1.","date":"2011","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/21576266","citation_count":93,"is_preprint":false},{"pmid":"21576265","id":"PMC_21576265","title":"The Dbp5 cycle at the nuclear pore complex during mRNA export I: dbp5 mutants with defects in RNA binding and ATP hydrolysis define key steps for Nup159 and Gle1.","date":"2011","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/21576265","citation_count":91,"is_preprint":false},{"pmid":"22064466","id":"PMC_22064466","title":"Dbp5, Gle1-IP6 and Nup159: a working model for mRNP export.","date":"2011","source":"Nucleus (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/22064466","citation_count":87,"is_preprint":false},{"pmid":"24243016","id":"PMC_24243016","title":"Gle1 functions during mRNA export in an oligomeric complex that is altered in human disease.","date":"2013","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/24243016","citation_count":71,"is_preprint":false},{"pmid":"20371601","id":"PMC_20371601","title":"Control of mRNA export and translation termination by inositol hexakisphosphate requires specific interaction with Gle1.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20371601","citation_count":71,"is_preprint":false},{"pmid":"16000379","id":"PMC_16000379","title":"Interaction between the shuttling mRNA export factor Gle1 and the nucleoporin hCG1: a conserved mechanism in the export of Hsp70 mRNA.","date":"2005","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/16000379","citation_count":71,"is_preprint":false},{"pmid":"14645504","id":"PMC_14645504","title":"The mRNA export factor human Gle1 interacts with the nuclear pore complex protein Nup155.","date":"2003","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/14645504","citation_count":55,"is_preprint":false},{"pmid":"12668658","id":"PMC_12668658","title":"An essential role for hGle1 nucleocytoplasmic shuttling in mRNA export.","date":"2003","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12668658","citation_count":52,"is_preprint":false},{"pmid":"22357925","id":"PMC_22357925","title":"A zebrafish model of lethal congenital contracture syndrome 1 reveals Gle1 function in spinal neural precursor survival and motor axon arborization.","date":"2012","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22357925","citation_count":47,"is_preprint":false},{"pmid":"15459192","id":"PMC_15459192","title":"Cytoplasmic inositol hexakisphosphate production is sufficient for mediating the Gle1-mRNA export pathway.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15459192","citation_count":45,"is_preprint":false},{"pmid":"28869701","id":"PMC_28869701","title":"Nup42 and IP6 coordinate Gle1 stimulation of Dbp5/DDX19B for mRNA export in yeast and human cells.","date":"2017","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/28869701","citation_count":40,"is_preprint":false},{"pmid":"21949122","id":"PMC_21949122","title":"Gle1 is a multifunctional DEAD-box protein regulator that modulates Ded1 in translation initiation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21949122","citation_count":39,"is_preprint":false},{"pmid":"15208322","id":"PMC_15208322","title":"Nuclear export of the yeast mRNA-binding protein Nab2 is linked to a direct interaction with Gfd1 and to Gle1 function.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15208322","citation_count":32,"is_preprint":false},{"pmid":"28035044","id":"PMC_28035044","title":"A role for Gle1, a regulator of DEAD-box RNA helicases, at centrosomes and basal bodies.","date":"2016","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/28035044","citation_count":31,"is_preprint":false},{"pmid":"19805289","id":"PMC_19805289","title":"Structure of the C-terminus of the mRNA export factor Dbp5 reveals the interaction surface for the ATPase activator Gle1.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19805289","citation_count":30,"is_preprint":false},{"pmid":"24275432","id":"PMC_24275432","title":"Insights into mRNA export-linked molecular mechanisms of human disease through a Gle1 structure-function analysis.","date":"2013","source":"Advances in biological regulation","url":"https://pubmed.ncbi.nlm.nih.gov/24275432","citation_count":26,"is_preprint":false},{"pmid":"26655997","id":"PMC_26655997","title":"Restoration of miR-127-3p and miR-376a-3p counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells by targeting COA1, GLE1 and PDIA6.","date":"2015","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/26655997","citation_count":26,"is_preprint":false},{"pmid":"26776475","id":"PMC_26776475","title":"An amyotrophic lateral sclerosis-linked mutation in GLE1 alters the cellular pool of human Gle1 functional isoforms.","date":"2015","source":"Advances in biological regulation","url":"https://pubmed.ncbi.nlm.nih.gov/26776475","citation_count":24,"is_preprint":false},{"pmid":"30429220","id":"PMC_30429220","title":"MAPK- and glycogen synthase kinase 3-mediated phosphorylation regulates the DEAD-box protein modulator Gle1 for control of stress granule dynamics.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30429220","citation_count":22,"is_preprint":false},{"pmid":"28784717","id":"PMC_28784717","title":"Gle1 Regulates RNA Binding of the DEAD-Box Helicase Ded1 in Its Complex Role in Translation Initiation.","date":"2017","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28784717","citation_count":20,"is_preprint":false},{"pmid":"29746542","id":"PMC_29746542","title":"Depletion of mRNA export regulator DBP5/DDX19, GLE1 or IPPK that is a key enzyme for the production of IP6, resulting in differentially altered cytoplasmic mRNA expression and specific cell defect.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29746542","citation_count":19,"is_preprint":false},{"pmid":"27684565","id":"PMC_27684565","title":"Expansion of the GLE1-associated arthrogryposis multiplex congenita clinical spectrum.","date":"2017","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27684565","citation_count":16,"is_preprint":false},{"pmid":"30262214","id":"PMC_30262214","title":"Gle1 mediates stress granule-dependent survival during chemotoxic stress.","date":"2018","source":"Advances in biological regulation","url":"https://pubmed.ncbi.nlm.nih.gov/30262214","citation_count":15,"is_preprint":false},{"pmid":"32460013","id":"PMC_32460013","title":"MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32460013","citation_count":14,"is_preprint":false},{"pmid":"35286399","id":"PMC_35286399","title":"The nucleoporin Gle1 activates DEAD-box protein 5 (Dbp5) by promoting ATP binding and accelerating rate limiting phosphate release.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/35286399","citation_count":11,"is_preprint":false},{"pmid":"28884921","id":"PMC_28884921","title":"Survival beyond the perinatal period expands the phenotypes caused by mutations in GLE1.","date":"2017","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/28884921","citation_count":11,"is_preprint":false},{"pmid":"29782832","id":"PMC_29782832","title":"Nup159 Weakens Gle1 Binding to Dbp5 But Does Not Accelerate ADP Release.","date":"2018","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29782832","citation_count":10,"is_preprint":false},{"pmid":"32981894","id":"PMC_32981894","title":"Functions of Gle1 are governed by two distinct modes of self-association.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32981894","citation_count":9,"is_preprint":false},{"pmid":"27630260","id":"PMC_27630260","title":"A mitotic nuclear envelope tether for Gle1 also impacts nuclear and nucleolar architecture.","date":"2016","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/27630260","citation_count":9,"is_preprint":false},{"pmid":"26921650","id":"PMC_26921650","title":"Deficiency in the mRNA export mediator Gle1 impairs Schwann cell development in the zebrafish embryo.","date":"2016","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26921650","citation_count":8,"is_preprint":false},{"pmid":"28729373","id":"PMC_28729373","title":"The importance of managing the patient and not the gene: expanded phenotype of GLE1-associated arthrogryposis.","date":"2017","source":"Cold Spring Harbor molecular case studies","url":"https://pubmed.ncbi.nlm.nih.gov/28729373","citation_count":6,"is_preprint":false},{"pmid":"18724928","id":"PMC_18724928","title":"Gle1 does double duty.","date":"2008","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/18724928","citation_count":6,"is_preprint":false},{"pmid":"28657126","id":"PMC_28657126","title":"A homozygous I684T in GLE1 as a novel cause of arthrogryposis and motor neuron loss.","date":"2017","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28657126","citation_count":5,"is_preprint":false},{"pmid":"32755435","id":"PMC_32755435","title":"Nucleocytoplasmic shuttling of Gle1 impacts DDX1 at transcription termination sites.","date":"2020","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/32755435","citation_count":4,"is_preprint":false},{"pmid":"32537934","id":"PMC_32537934","title":"Extension of the phenotypic spectrum of GLE1-related disorders to a mild congenital form resembling congenital myopathy.","date":"2020","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32537934","citation_count":3,"is_preprint":false},{"pmid":"31344122","id":"PMC_31344122","title":"Correction: Depletion of mRNA export regulator DBP5/DDX19, GLE1 or IPPK that is a key enzyme for the production of IP6, resulting in differentially altered cytoplasmic mRNA expression and specific cell defect.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31344122","citation_count":3,"is_preprint":false},{"pmid":"34025336","id":"PMC_34025336","title":"Mutation Screening of the GLE1 Gene in a Large Chinese Cohort of Amyotrophic Lateral Sclerosis Patients.","date":"2021","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/34025336","citation_count":2,"is_preprint":false},{"pmid":"38189406","id":"PMC_38189406","title":"Gle1 is required for tRNA to stimulate Dbp5 ATPase activity in vitro and promote Dbp5-mediated tRNA export in vivo in Saccharomyces cerevisiae.","date":"2024","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/38189406","citation_count":2,"is_preprint":false},{"pmid":"29398120","id":"PMC_29398120","title":"Screening of GLE1 mutations in Chinese amyotrophic lateral sclerosis patients.","date":"2018","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/29398120","citation_count":2,"is_preprint":false},{"pmid":"30565205","id":"PMC_30565205","title":"The expression of SMN1, MART3, GLE1 and FUS genes in spinal muscular atrophy.","date":"2018","source":"Folia histochemica et cytobiologica","url":"https://pubmed.ncbi.nlm.nih.gov/30565205","citation_count":1,"is_preprint":false},{"pmid":"37425677","id":"PMC_37425677","title":"Gle1 is required for tRNA to stimulate Dbp5 ATPase activity in vitro and to promote Dbp5 mediated tRNA export in vivo.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/37425677","citation_count":1,"is_preprint":false},{"pmid":"37801910","id":"PMC_37801910","title":"Phosphorylation impacts GLE1 nuclear localization and association with DDX1.","date":"2023","source":"Advances in biological regulation","url":"https://pubmed.ncbi.nlm.nih.gov/37801910","citation_count":0,"is_preprint":false},{"pmid":"40004126","id":"PMC_40004126","title":"Molecular Structure of the mRNA Export Factor Gle1 from Debaryomyces hansenii.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40004126","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.10.14.618161","title":"GLE1 dysfunction compromises cellular homeostasis, spatial organization, and peripheral axon branching","date":"2024-10-16","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.14.618161","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.10.27.684907","title":"Structure-Aware Mapping of Disease-Relevant Missense Variation: A Case Study in Three Nuclear Pore Complex Genes","date":"2025-10-29","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.27.684907","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.12.03.626577","title":"Chemically Induced Nuclear Pore Complex Protein Degradation via E3 Ligase TRIM21","date":"2024-12-04","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.03.626577","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":25366,"output_tokens":8248,"usd":0.099909,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17820,"output_tokens":6784,"usd":0.12935,"stage2_stop_reason":"end_turn"},"total_usd":0.229259,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"Gle1 and inositol hexakisphosphate (InsP6) together stimulate the RNA-dependent ATPase activity of the DEAD-box protein Dbp5 at the nuclear pore complex. In vitro kinetic analysis showed InsP6 significantly increased Dbp5 ATPase activity in a Gle1-dependent manner and lowered the effective RNA concentration for half-maximal ATPase activity. Gle1 alone had minimal stimulatory effect. Maximal InsP6 binding required both Dbp5 and Gle1.\",\n      \"method\": \"In vitro ATPase kinetic assays, genetic suppression (overexpression of DBP5 suppressed mRNA export defects of ipk1 nup42 mutant)\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with kinetic analysis, replicated simultaneously by two independent labs (PMIDs 16783363 and 16783364)\",\n      \"pmids\": [\"16783363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Gle1 directly binds InsP6 and this binding potentiates Gle1-mediated stimulation of Dbp5 ATPase and RNA-binding activities. A gle1 point mutant deficient for Dbp5 stimulation in vitro displays an mRNA export defect in vivo, establishing that Dbp5 activation is an essential function of Gle1.\",\n      \"method\": \"In vitro ATPase and RNA-binding assays, in vitro binding, dominant mutations in DBP5 and GLE1 that rescue InsP6-deficient mRNA export phenotypes, in vivo mRNA export assays\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution plus mutagenesis plus in vivo rescue, replicated simultaneously by independent lab (PMID 16783363)\",\n      \"pmids\": [\"16783364\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Gle1 and IP6 are required for efficient translation termination in S. cerevisiae; Gle1 physically interacts with translation termination factors. Additionally, Gle1 has a conserved physical association with the initiation factor eIF3, and gle1 mutants display genetic interactions with the eIF3 mutant nip1-1. gle1 mutants have defects in translation initiation independently of IP6.\",\n      \"method\": \"Genetic interaction analysis, co-immunoprecipitation (Gle1-eIF3 interaction), in vivo translation termination and initiation assays in yeast mutants\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, genetic epistasis, multiple orthogonal functional assays in single study\",\n      \"pmids\": [\"18724935\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Specific Gle1 residues are required for IP6 binding, and these same residues are needed for IP6-dependent Dbp5 stimulation in vitro. In vivo, IP6-binding mutants of Gle1 recapitulate all mRNA export and translation termination defects seen in IP6-depleted cells, establishing Gle1 as the primary target of IP6 for both processes.\",\n      \"method\": \"In vitro ATPase stimulation assays with Gle1 point mutants, in vivo mRNA export and translation termination assays in S. cerevisiae\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — structure-guided mutagenesis combined with in vitro biochemistry and in vivo phenotypic analysis, multiple orthogonal methods\",\n      \"pmids\": [\"20371601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nup159 is specifically required for ADP release from Dbp5, whereas Gle1-IP6 stimulates ATP binding to Dbp5, priming it for RNA loading. A Dbp5 mutant with reduced ADP binding bypasses the need for Nup159 interaction in vivo. Together, Nup159 and Gle1-IP6 regulate Dbp5 cycles by controlling its nucleotide-bound state, allowing multiple cycles of mRNP remodeling at the NPC.\",\n      \"method\": \"In vitro reconstitution ATPase assays, genetic suppressor analysis (dbp5-R256D/R259D bypass of Nup159), in vivo mRNA export assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution plus genetic epistasis plus in vivo phenotypic rescue, multiple orthogonal methods in one study\",\n      \"pmids\": [\"21576266\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ATP binding and hydrolysis are required for efficient Dbp5 association with NPCs. RNA-binding-deficient Dbp5 mutants are dominant-negative for mRNA export by competing with wild-type Dbp5 for Gle1 at NPCs. The Dbp5-Gle1 interaction is limiting for export and can be independent of Nup159. FRAP shows Dbp5 associates with NPCs for less than 1 second on average.\",\n      \"method\": \"Dominant-negative mutant analysis in yeast and human cells, FRAP (fluorescence recovery after photobleaching), in vivo mRNA export assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — dominant-negative competition assays, live-cell FRAP, multiple orthogonal methods, replicated in both yeast and human cells\",\n      \"pmids\": [\"21576265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Gle1 physically and genetically interacts with the DEAD-box protein Ded1 (a translation initiation factor). Unlike its stimulation of Dbp5, Gle1 inhibits Ded1 ATPase activity in vitro, and this inhibition is independent of IP6. A gle1-4 mutant suppresses translation initiation defects in ded1-120 mutant. Gle1 inhibits translation in vitro in competent extracts.\",\n      \"method\": \"In vitro ATPase assay (Gle1 inhibition of Ded1), genetic suppressor analysis (gle1-4 suppresses ded1-120), in vitro translation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of inhibitory activity, genetic epistasis, in vitro translation assay, multiple orthogonal methods\",\n      \"pmids\": [\"21949122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The N-terminal 29 residues of hGle1 constitute the hNup155-binding domain. The hGle1-hNup155 interaction is necessary for NPC localization of hGle1. hNup155 C-terminal 177 amino acids bind hGle1. Deletion of the N-terminal 29 residues of hGle1B abolished nuclear rim localization in HeLa cells.\",\n      \"method\": \"Yeast two-hybrid screen, in vitro binding assay, deletion analysis, fluorescence microscopy in HeLa cells\",\n      \"journal\": \"Molecular & cellular proteomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro binding plus deletion analysis plus cell localization, single lab\",\n      \"pmids\": [\"14645504\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"hGle1 undergoes nucleocytoplasmic shuttling between the nucleus and cytoplasm. An internal 39-amino acid shuttling domain is necessary and sufficient for nucleocytoplasmic transport. Disruption of shuttling by a cell-permeable peptide impairs export of bulk poly(A)+ RNA and specific mRNA and reduces hGle1 localization at the nuclear envelope.\",\n      \"method\": \"Microinjection of recombinant hGle1, FRAP in live HeLa cells expressing EGFP-hGle1, cell-permeable peptide inhibition, mRNA export assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — live-cell FRAP, microinjection, peptide inhibition with functional mRNA export readout, multiple orthogonal methods\",\n      \"pmids\": [\"12668658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The unique C-terminal 43 amino acid region of hGle1B mediates binding to the C-terminal non-FG region of nucleoporin hCG1/NPL1. hNup155, hGle1B, and hCG1 form a heterotrimeric complex in vitro. siRNA-mediated depletion of hCG1 causes hGle1 accumulation in cytoplasmic foci and inhibits Hsp70 mRNA export and Hsp70 protein production.\",\n      \"method\": \"In vitro binding assay (heterotrimeric complex reconstitution), siRNA knockdown, mRNA export assay, fluorescence microscopy\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vitro complex reconstitution, siRNA functional knockdown with mRNA export readout, multiple orthogonal methods\",\n      \"pmids\": [\"16000379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Nab2, Gfd1, and Gle1 associate in a complex. Direct in vitro binding assay revealed a direct association between Nab2 and Gfd1. Nuclear export of Nab2 was blocked in a gle1 mutant at the restrictive temperature, placing Gle1 in the pathway for Nab2-bound mRNA export.\",\n      \"method\": \"Affinity isolation with recombinant proteins from yeast lysates, co-immunoprecipitation, in vitro binding assay, in vivo export assay in gle1 temperature-sensitive mutant\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal pulldowns plus in vivo epistasis, single lab\",\n      \"pmids\": [\"15208322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Cytoplasmic production of IP6 by plasma membrane-anchored Ipk1 is sufficient to rescue mRNA export defects of a gle1-2 ipk1-4 synthetic lethal mutant, establishing that the IP6 requirement for Gle1-mediated mRNA export operates at the cytoplasmic face of the NPC.\",\n      \"method\": \"Genetic rescue (cytoplasm-restricted Ipk1 complementation of gle1-2 ipk1-4 synthetic lethal), spatial restriction of IP6-producing enzymes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with spatial-restriction complementation, single lab\",\n      \"pmids\": [\"15459192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structure of the C-terminal domain of Dbp5 (1.8 Å) revealed a RecA-like fold with a unique C-terminal alpha-helix and a loop connecting beta5 and alpha4 not present in other DExD/H-box proteins. Structure-guided mutagenesis identified charged surface residues whose mutation weakens Gle1 binding and inhibits Gle1-stimulated Dbp5 ATPase activity in vitro; the same mutations were unable to support yeast growth, demonstrating that Gle1-Dbp5 interaction is required for cellular mRNA export.\",\n      \"method\": \"X-ray crystallography (1.8 Å), structure-guided mutagenesis, in vitro ATPase stimulation assay, in vivo growth complementation assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus structure-guided mutagenesis validated by in vitro and in vivo assays, multiple orthogonal methods in one study\",\n      \"pmids\": [\"19805289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Gle1 self-associates via its coiled-coil domain both in vitro and in living cells, forming ~26 nm diameter disk-shaped oligomeric particles visible by electron microscopy. The disease-causing FinMajor mutation (proline-phenylalanine-glutamine insertion) disrupts proper Gle1 oligomer formation. Correct Gle1 oligomerization is specifically required for mRNA export function but not for Gle1's roles in translation.\",\n      \"method\": \"In vitro self-association assay, live-cell imaging (fluorescence), electron microscopy, functional mRNA export and translation assays with oligomerization-deficient mutants\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — EM structural characterization, in vitro biochemistry, live-cell imaging, and functional separation-of-function mutants, multiple orthogonal methods\",\n      \"pmids\": [\"24243016\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The Nup42 C-terminal domain (CTD) binds Gle1/hGle1B at an interface distinct from the Gle1-Dbp5 interaction site. A trimeric Nup42-CTD/Gle1-CTD/Dbp5 complex forms in the presence of IP6. Deletion of NUP42 abrogates the Gle1-Dbp5 interaction. In vitro, Nup42-CTD and IP6 stimulate Gle1/hGle1B activation of Dbp5 and hDDX19B in similar, non-additive manners. Disruption of the Nup42 or IP6 binding interfaces on Gle1/hGle1B causes defective mRNA export in yeast and human cells.\",\n      \"method\": \"In vitro ATPase stimulation assay, trimeric complex reconstitution, genetic deletion analysis, mRNA export assay in yeast and human cells, structure-function mutagenesis\",\n      \"journal\": \"Traffic (Copenhagen, Denmark)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of trimeric complex, ATPase assays, validated in both yeast and human cells with multiple mutants\",\n      \"pmids\": [\"28869701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Gle1 inhibits Ded1 RNA binding to reduce Ded1 ATPase activity and repress translation, acting as a gatekeeper to optimize Ded1 activity. Mutation analysis and binding assays show Gle1 inhibits Ded1 by reducing its affinity for RNA. Both Ded1 and Gle1 affect assembly of preinitiation complexes.\",\n      \"method\": \"In vitro ATPase assay, RNA-binding assay, in vivo translation assays, genetic epistasis (GLE1 suppression of DED1 overexpression defects), preinitiation complex assembly assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of inhibitory mechanism (RNA binding), in vivo genetic validation, multiple orthogonal methods\",\n      \"pmids\": [\"28784717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Human Gle1 is regulated by phosphorylation during heat shock stress. MS identified 14 phosphorylation sites in Gle1A, with six clustering in an N-terminal intrinsically disordered region. ERK and JNK phosphorylate the Gle1A N-terminal domain, priming it for glycogen synthase kinase 3 (GSK3) phosphorylation. A phosphomimetic gle1A6D variant perturbed self-association and inhibited DDX3 ATPase activity. Phosphodeficient GFP-gle1A6A promoted stress granule assembly, whereas GFP-gle1A6D enhanced stress granule disassembly.\",\n      \"method\": \"Mass spectrometry (phosphosite identification), in vitro kinase assay (ERK, JNK, GSK3), phosphomimetic and phosphodeficient mutant analysis, in vitro ATPase assay (DDX3 inhibition), stress granule imaging in HeLa cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — MS-identified sites validated by in vitro kinase assays, ATPase inhibition, and functional cell biology with phosphomimetic mutants, multiple orthogonal methods\",\n      \"pmids\": [\"30429220\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Gle1A isoform is required for proper stress granule formation and the sodium arsenite survival response in HeLa cells. Gle1B functions in mRNA export at the nuclear pore complex. The two isoforms have spatially distinct functions: Gle1A in cytoplasmic stress granules, Gle1B at the nuclear envelope.\",\n      \"method\": \"siRNA knockdown of hGle1, overexpression of Gle1A isoform, stress granule imaging, cell survival assay\",\n      \"journal\": \"Advances in biological regulation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific knockdown/overexpression with functional stress granule and survival readouts, single lab\",\n      \"pmids\": [\"30262214\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Gle1 localizes to centrosomes and basal bodies, assembling into the toroid-shaped pericentriolar material around the mother centriole. Reduced Gle1 levels correlate with decreased pericentrin localization and microtubule organization defects independently of mRNA export loss. In Gle1-depleted zebrafish, Kupffer's vesicle shows compromised ciliary beating and developmental defects.\",\n      \"method\": \"Fluorescence microscopy (localization), siRNA/morpholino knockdown, centrosome/microtubule phenotype analysis, zebrafish ciliary beating assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization by fluorescence microscopy with functional consequence (microtubule organization, ciliary beating), single lab\",\n      \"pmids\": [\"28035044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Gle1 activates Dbp5 by two mechanisms: (1) Gle1 binding to Dbp5-ATP is thermodynamically coupled, with Gle1 binding Dbp5-ATP >100-fold more tightly than other nucleotide states, slowing ATP dissociation >150-fold; (2) Gle1 accelerates the rate-limiting phosphate (Pi) release step ~20-fold. These activities ensure a pool of ATP-bound Dbp5 at NPCs for RNA engagement during export.\",\n      \"method\": \"In vitro kinetic and equilibrium ATPase analysis (stopped-flow, fluorescence-based assays) with S. cerevisiae Gle1 and Dbp5\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — detailed kinetic reconstitution with multiple equilibrium and rate measurements, single lab but multiple orthogonal biochemical approaches\",\n      \"pmids\": [\"35286399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Nup159 did not accelerate ADP release from Dbp5, contradicting the proposed nucleotide exchange factor model. Instead, Gle1 slowed ADP release from Dbp5 independent of Mg2+. In the presence of Nup159, the Gle1-ADP-Dbp5 interaction was reduced ~18-fold, suggesting Nup159 promotes Gle1 release from Dbp5 rather than ADP release.\",\n      \"method\": \"In vitro solution-based kinetic and thermodynamic assays (nucleotide binding/release measurements)\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — rigorous in vitro kinetics, but single lab; directly contradicts prior model (negative finding for Nup159 as ADP release factor)\",\n      \"pmids\": [\"29782832\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Gle1 self-association is driven by two distinct regions: a coiled-coil domain and a novel 10-amino acid aggregation-prone region. Gle1 oligomerization is necessary for mRNA export and stress granule formation (additively requiring both domains) and for translation regulation under stress (each domain independently required). Gle1 self-association is dispensable for phosphorylation and non-stressed translation initiation.\",\n      \"method\": \"Mutagenesis of oligomerization domains, exogenous expression in HeLa cells, mRNA export assay, stress granule imaging, translation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic mutagenesis with multiple functional readouts, single lab\",\n      \"pmids\": [\"32981894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Gle1 physically interacts with the RNA-binding E3 ubiquitin ligase MKRN2. In zebrafish, morpholino knockdown or CRISPR/Cas9 knockout of MKRN2 partially rescues retinal developmental defects caused by GLE1 depletion, establishing a functional epistatic relationship between GLE1 and MKRN2 in mRNA export and retinal development.\",\n      \"method\": \"Affinity-purification mass spectrometry (interaction identification), morpholino knockdown, CRISPR/Cas9 knockout, zebrafish genetic epistasis (rescue assay), ribonomic analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — AP-MS interaction plus genetic epistasis in zebrafish, single lab\",\n      \"pmids\": [\"32460013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Nuclear accumulation of Gle1 (via shuttling inhibition) results in accumulation of specific mRNAs with elongated 3'-UTRs due to altered transcription termination, not altered nuclear export. Gle1 shuttling inhibition increased DDX1 nucleoplasmic localization and decreased DDX1 interactions with Gle1 and with CstF-64 (pre-mRNA cleavage stimulation factor). Gle1 colocalized with nuclear R-loops, and shuttling inhibition increased nuclear R-loop signal intensity.\",\n      \"method\": \"Cell-permeable peptide to disrupt shuttling, RNA-seq/mRNA accumulation analysis, immunofluorescence (DDX1, R-loop localization), co-immunoprecipitation (Gle1-DDX1-CstF-64 interaction)\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional peptide inhibition combined with co-IP and localization, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"32755435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Phosphorylation of Gle1 at threonine 102 (T102) serves as a priming event for further N-terminal phosphorylation. Basally phosphorylated (T102) Gle1 is predominantly nuclear; under sodium arsenite stress, more cytoplasmic localization is detected. Gle1-pT102 co-immunoprecipitates with DDX1 in a phosphatase-sensitive manner. Disruption of Gle1 nucleocytoplasmic shuttling decreased total Gle1-DDX1 association but increased co-isolation of Gle1-pT102 with DDX1.\",\n      \"method\": \"Phospho-specific antibody generation, in vitro kinase assay, indirect immunofluorescence microscopy, co-immunoprecipitation\",\n      \"journal\": \"Advances in biological regulation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro kinase assay plus phospho-specific antibody with co-IP and localization readouts, single lab\",\n      \"pmids\": [\"37801910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Gle1 binding to Dbp5 (via the Gle1-Dbp5 interaction interface) is required for Dbp5 to mediate tRNA export in vivo, as shown by dominant-negative Dbp5 mutants. tRNA acts synergistically with Gle1 to fully activate Dbp5 ATPase activity; direct Dbp5-tRNA interaction alone does not stimulate ATPase activity.\",\n      \"method\": \"In vitro ATPase assay (Dbp5 + tRNA ± Gle1), dominant-negative overexpression in vivo, co-immunoprecipitation (Dbp5-tRNA), genetic epistasis (dbp5 mutants parallel to los1)\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro biochemistry plus in vivo genetics, single lab\",\n      \"pmids\": [\"38189406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"hGle1 localization to nuclear pore complexes requires interaction with hCG1 (via the unique C-terminal 43 aa of hGle1B); siRNA-mediated depletion of hCG1 causes hGle1 accumulation in cytoplasmic foci, indicating hCG1 is required for NPC localization of hGle1. This parallels the yeast Gle1-Nup42/Rip1 interaction.\",\n      \"method\": \"siRNA knockdown, fluorescence microscopy, in vitro binding/complex assembly assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with fluorescence localization readout plus in vitro binding, single lab\",\n      \"pmids\": [\"16000379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"An ALS-linked hGLE1 splice site mutation (c.1965-2A>C) generates a novel protein isoform (hGle1-IVS14-2A>C) with an 88 amino acid C-terminal insertion. This isoform localizes to stress granules (like hGle1A), rescues stress granule defects upon hGle1 depletion, and can also rescue mRNA export defects — acting in a bi-functional manner combining hGle1A and hGle1B functions. Both hGle1A and hGle1-IVS14-2A>C overexpression induced cytoplasmic protein aggregates.\",\n      \"method\": \"Molecular cloning of mutant isoform, GFP-tagged localization by fluorescence microscopy, siRNA rescue assay (stress granule and mRNA export), overexpression aggregate formation\",\n      \"journal\": \"Advances in biological regulation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional isoform characterization with multiple cellular readouts, single lab\",\n      \"pmids\": [\"26776475\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Two deleterious ALS-linked hGLE1 mutations cause depletion of hGle1 from the nuclear pore in HeLa cells and fail to rescue motor neuron pathology in zebrafish morphants lacking Gle1, consistent with haploinsufficiency as the ALS mechanism.\",\n      \"method\": \"Fluorescence microscopy (hGle1 nuclear pore localization in HeLa), zebrafish morphant rescue assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell localization plus in vivo zebrafish rescue assay, single lab\",\n      \"pmids\": [\"25343993\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Crystal structure of N-terminally truncated Gle1 from Debaryomyces hansenii (DhGle1ΔN) was determined at 1.5 Å resolution, revealing 13 α-helices. Structural comparison with homologs showed no significant conformational changes upon complex formation, but identified distinct secondary structural elements in α1, α3, α4, and α8 that may be relevant to partner interactions.\",\n      \"method\": \"X-ray crystallography (1.5 Å), structural comparison with homologs\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 1 / Weak — crystal structure determined but no functional mutagenesis validation reported in abstract; single study, fungal ortholog\",\n      \"pmids\": [\"40004126\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GLE1 is a conserved, multifunctional regulator of RNA-dependent DEAD-box ATPases that localizes to the cytoplasmic face of nuclear pore complexes (via interactions with Nup155 and hCG1/Nup42) through nucleocytoplasmic shuttling; at the NPC, GLE1 bound to inositol hexakisphosphate (IP6) activates the DEAD-box protein Dbp5 by promoting ATP binding and accelerating rate-limiting phosphate release, thereby driving mRNP remodeling for directional mRNA export, while Nup159 facilitates Gle1 release from Dbp5 after each cycle; beyond export, GLE1 independently regulates translation initiation by inhibiting Ded1 RNA-binding activity, coordinates translation termination together with IP6 and Dbp5, controls stress granule dynamics through isoform-specific (Gle1A) cytoplasmic functions regulated by MAPK/GSK3-mediated phosphorylation, participates in transcription termination via nuclear DDX1 interactions, and localizes to centrosomes/basal bodies where it supports microtubule organization; loss-of-function mutations in GLE1 cause lethal congenital contracture syndrome 1 (LCCS1) and related motor neuron diseases by disrupting oligomerization-dependent mRNA export and broader mRNA metabolism.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GLE1 is a conserved, multifunctional regulator of RNA-dependent DEAD-box ATPases that governs directional mRNA export at the nuclear pore complex (NPC) and additionally tunes translation [#0, #6]. At the cytoplasmic face of the NPC, GLE1 bound to inositol hexakisphosphate (IP6) activates the DEAD-box protein Dbp5: GLE1-IP6 promotes ATP binding to prime Dbp5 for RNA loading and accelerates the rate-limiting phosphate release step, thereby driving the mRNP-remodeling cycles required for export [#0, #1, #4, #19]. Specific GLE1 residues mediate IP6 binding, and the same residues are required for Dbp5 stimulation in vitro and for mRNA export and translation termination in vivo, establishing IP6-bound GLE1 as the operative activating species [#3]. GLE1 is recruited to the NPC through its nucleoporin contacts—an N-terminal hNup155-binding domain and a C-terminal hCG1/Nup42-binding region that together with Dbp5 and IP6 assemble an activating complex—and through nucleocytoplasmic shuttling that is itself required for efficient poly(A)+ RNA export [#7, #9, #14, #8]. GLE1 self-associates through a coiled-coil and an aggregation-prone region into disk-shaped oligomers; this oligomerization is specifically required for mRNA export but separable from its translation roles, and the disease-causing FinMajor insertion disrupts it [#13, #21]. Beyond export, GLE1 acts as a translational gatekeeper by inhibiting the DEAD-box initiation factor Ded1 through reduction of its RNA-binding affinity, an IP6-independent activity, and cooperates with IP6 and Dbp5 in translation termination [#6, #15, #2]. An isoform-specific cytoplasmic function (Gle1A), regulated by ERK/JNK-primed GSK3 phosphorylation, controls stress-granule assembly and disassembly and modulates DDX3 activity, while GLE1 also influences transcription termination via DDX1 interactions and localizes to centrosomes to support microtubule organization [#16, #17, #18, #23]. Loss-of-function GLE1 mutations cause lethal congenital contracture syndrome 1 and ALS-associated motor neuron pathology by depleting GLE1 from the NPC and disrupting oligomerization-dependent mRNA export [#13, #28].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"Established the core biochemical function of GLE1: how an inositol phosphate cofactor and GLE1 jointly switch on the export ATPase Dbp5, resolving how nucleotide-dependent mRNP remodeling is activated at the pore.\",\n      \"evidence\": \"In vitro ATPase kinetics and in vitro IP6/protein binding with genetic suppression in yeast, replicated by two independent labs\",\n      \"pmids\": [\"16783363\", \"16783364\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the GLE1 residues mediating IP6 binding\", \"Mechanism by which IP6 alters Dbp5 kinetics not yet resolved at the step level\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Localized the IP6 requirement to the cytoplasmic face of the NPC, showing GLE1-dependent export operates spatially where mRNP is released.\",\n      \"evidence\": \"Genetic rescue with cytoplasm-restricted Ipk1 in gle1-2 ipk1-4 synthetic-lethal yeast\",\n      \"pmids\": [\"15459192\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Did not directly visualize the activating complex at the pore\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defined how GLE1 reaches the NPC—identifying a discrete Nup155-binding domain and nucleocytoplasmic shuttling as prerequisites for nuclear-rim localization and bulk mRNA export.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro binding, deletion analysis, microinjection and FRAP in HeLa cells with mRNA export readout\",\n      \"pmids\": [\"14645504\", \"12668658\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the shuttling receptor\", \"Relationship between shuttling and Dbp5 activation not addressed\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identified the second nucleoporin anchor (hCG1/Nup42) and reconstituted a Nup155-Gle1B-hCG1 heterotrimer, showing both contacts are needed for NPC retention and efficient mRNA export.\",\n      \"evidence\": \"In vitro complex reconstitution, siRNA depletion of hCG1, mRNA export and protein production assays\",\n      \"pmids\": [\"16000379\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not place hCG1 mechanistically in the Dbp5 activation cycle (resolved later)\", \"Single lab for human system\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Extended GLE1 function beyond export to translation, demonstrating roles in termination (with IP6) and initiation (via eIF3) that are partly IP6-independent.\",\n      \"evidence\": \"Genetic interaction analysis, reciprocal co-IP, in vivo translation termination and initiation assays in yeast\",\n      \"pmids\": [\"18724935\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular target of the initiation activity not identified here\", \"Did not separate export from translation functions structurally\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Provided the structural basis of the Gle1-Dbp5 interface, mapping surface residues whose mutation abolishes stimulation and cell viability.\",\n      \"evidence\": \"1.8 Å crystal structure of Dbp5 C-terminal domain with structure-guided mutagenesis and in vitro/in vivo assays\",\n      \"pmids\": [\"19805289\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of the GLE1-IP6-Dbp5 complex\", \"GLE1 conformation in the complex unresolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Pinpointed GLE1 as the primary IP6 target, showing the IP6-binding residues are required for both export and translation termination in vivo.\",\n      \"evidence\": \"Structure-guided GLE1 point mutants in in vitro ATPase and in vivo export/termination assays in yeast\",\n      \"pmids\": [\"20371601\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address how IP6 binding feeds into the kinetic steps of Dbp5 cycling\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Resolved the directionality of the Dbp5 cycle, dividing labor between GLE1-IP6 (ATP binding/RNA loading) and Nup159 (downstream release), and showed the Gle1-Dbp5 interaction is the limiting export step with sub-second pore dwell time.\",\n      \"evidence\": \"In vitro reconstitution ATPase assays, genetic suppressor bypass, dominant-negative competition, and FRAP in yeast and human cells\",\n      \"pmids\": [\"21576266\", \"21576265\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of Nup159 action initially modeled as ADP release was later revised\", \"Did not directly measure ATP-binding or Pi-release rate constants\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Revealed that GLE1 acts oppositely on different DEAD-box proteins—inhibiting the initiation factor Ded1 in an IP6-independent manner—establishing GLE1 as a bidirectional ATPase regulator.\",\n      \"evidence\": \"In vitro ATPase and translation assays with genetic suppressor analysis (gle1-4 suppresses ded1-120)\",\n      \"pmids\": [\"21949122\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of Ded1 inhibition not yet defined (later shown to be via RNA binding)\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showed GLE1 self-assembles into oligomeric particles and that this oligomerization is selectively required for export but not translation, linking it directly to disease via the FinMajor mutation.\",\n      \"evidence\": \"In vitro self-association, EM, live-cell imaging, and separation-of-function mutants in export/translation assays\",\n      \"pmids\": [\"24243016\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic structure of the oligomer not determined\", \"How oligomerization couples to Dbp5 activation unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Integrated the nucleoporin anchor into the activation mechanism, showing Nup42-CTD and IP6 non-additively stimulate GLE1 activation of Dbp5/DDX19B as part of a trimeric complex.\",\n      \"evidence\": \"In vitro trimeric complex reconstitution, ATPase assays, and export assays in yeast and human cells\",\n      \"pmids\": [\"28869701\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve a structure of the full activating assembly\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined the molecular mechanism of Ded1 repression—GLE1 reduces Ded1 RNA affinity to act as a translation-initiation gatekeeper affecting preinitiation complex assembly.\",\n      \"evidence\": \"In vitro ATPase and RNA-binding assays, in vivo translation assays, genetic epistasis, preinitiation complex assays\",\n      \"pmids\": [\"28784717\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the GLE1-Ded1 interaction unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Established phospho-regulation of cytoplasmic GLE1 (Gle1A), showing an ERK/JNK-primed, GSK3-driven phospho-code controls self-association, DDX3 activity, and stress-granule dynamics.\",\n      \"evidence\": \"Mass spectrometry, in vitro kinase assays, phosphomimetic/phosphodeficient mutants, ATPase assays, and stress-granule imaging in HeLa cells\",\n      \"pmids\": [\"30429220\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo physiological triggers of each kinase event not mapped\", \"Single lab for stress-granule phenotypes\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Assigned spatially distinct roles to the GLE1 isoforms—Gle1A in cytoplasmic stress-granule formation and survival, Gle1B at the nuclear envelope for export.\",\n      \"evidence\": \"Isoform-specific siRNA/overexpression with stress-granule imaging and survival assays in HeLa cells\",\n      \"pmids\": [\"30262214\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Endogenous isoform ratios and switching not quantified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Revised the Nup159 model, showing in solution kinetics that Nup159 does not accelerate ADP release but instead promotes GLE1 release from Dbp5.\",\n      \"evidence\": \"In vitro solution kinetic and thermodynamic nucleotide binding/release measurements\",\n      \"pmids\": [\"29782832\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; contradicts earlier model and awaits independent reconciliation\", \"In vivo relevance of the revised mechanism not tested directly\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Dissected the two self-association determinants of GLE1 and their differential requirements across export, stress-granule formation, and stress translation.\",\n      \"evidence\": \"Mutagenesis of oligomerization domains with export, stress-granule, and translation readouts in HeLa cells\",\n      \"pmids\": [\"32981894\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Structural mechanism of the aggregation-prone region not resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Implicated GLE1 in transcription termination, showing shuttling inhibition causes 3'-UTR elongation, altered DDX1/CstF-64 interactions, and increased nuclear R-loops independent of export.\",\n      \"evidence\": \"Cell-permeable shuttling-disruption peptide, RNA-seq, immunofluorescence, and co-IP\",\n      \"pmids\": [\"32755435\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Direct enzymatic role of GLE1 in termination not established\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified a new physical and functional partner, the E3 ligase MKRN2, with genetic epistasis linking GLE1 and MKRN2 in mRNA export and retinal development.\",\n      \"evidence\": \"AP-MS, zebrafish morpholino/CRISPR knockout rescue, ribonomic analysis\",\n      \"pmids\": [\"32460013\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Mechanistic basis of the GLE1-MKRN2 functional interaction unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Provided the quantitative kinetic mechanism of Dbp5 activation, showing GLE1 thermodynamically traps the ATP-bound state and accelerates the rate-limiting Pi-release step.\",\n      \"evidence\": \"Stopped-flow and equilibrium ATPase kinetic analysis with yeast GLE1 and Dbp5\",\n      \"pmids\": [\"35286399\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single lab\", \"Structural snapshots of the kinetic intermediates not obtained\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified GLE1 T102 as a priming phosphosite that biases nuclear localization and modulates phosphatase-sensitive DDX1 association.\",\n      \"evidence\": \"Phospho-specific antibody, in vitro kinase assay, immunofluorescence, and co-IP\",\n      \"pmids\": [\"37801910\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Functional consequence of T102 phosphorylation for export/termination not directly tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended GLE1-Dbp5 function to tRNA export, showing the Gle1-Dbp5 interface is required in vivo and that tRNA synergizes with GLE1 to fully activate Dbp5 ATPase activity.\",\n      \"evidence\": \"In vitro ATPase assays, dominant-negative overexpression, co-IP, and genetic epistasis in yeast\",\n      \"pmids\": [\"38189406\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Whether human GLE1 supports tRNA export not addressed\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Connected GLE1 to motor neuron disease at the molecular level, characterizing an ALS-linked splice isoform with combined export and stress-granule functions.\",\n      \"evidence\": \"Molecular cloning, GFP-localization, siRNA rescue assays, and aggregate-formation analysis\",\n      \"pmids\": [\"26776475\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Pathogenic mechanism of the cytoplasmic aggregates not established\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrated that ALS-linked GLE1 mutations deplete GLE1 from the NPC and fail to rescue motor neuron pathology, supporting haploinsufficiency as the disease mechanism.\",\n      \"evidence\": \"Fluorescence microscopy in HeLa and zebrafish morphant rescue assays\",\n      \"pmids\": [\"25343993\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Did not establish a mammalian in vivo model of the disease\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Provided a high-resolution structure of a fungal GLE1 ortholog, identifying secondary-structure elements potentially relevant to partner interactions.\",\n      \"evidence\": \"1.5 Å X-ray crystallography of DhGle1ΔN with structural comparison to homologs\",\n      \"pmids\": [\"40004126\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No functional mutagenesis validation\", \"Fungal ortholog; relevance to human GLE1 interfaces not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How GLE1's distinct activities—export-coupled Dbp5 activation, Ded1/DDX3 inhibition, transcription termination, and centrosomal microtubule organization—are coordinated within a single cell, and the structure of the assembled GLE1-IP6-Dbp5-nucleoporin activating complex, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structure of the full activating complex\", \"Mechanism integrating nuclear and cytoplasmic GLE1 functions unknown\", \"Centrosomal role mechanistically uncharacterized at the molecular level\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 6, 15, 19]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [1, 3]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [7, 9, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005635\", \"supporting_discovery_ids\": [7, 8, 9, 17]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [8, 16, 17]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [8, 24]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 1, 4, 14]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [2, 6, 15]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [8, 9]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [16, 17]}\n    ],\n    \"complexes\": [\n      \"Nup155-Gle1B-hCG1/Nup42 NPC complex\",\n      \"Gle1-IP6-Dbp5 activating complex\",\n      \"Gle1 coiled-coil homo-oligomer\"\n    ],\n    \"partners\": [\n      \"DBP5/DDX19B\",\n      \"NUP155\",\n      \"NUP42\",\n      \"DED1\",\n      \"DDX1\",\n      \"DDX3\",\n      \"MKRN2\",\n      \"NAB2\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}